Xi'an International Medical Investment Company Limited (SHE:000516)
China · Delayed Price · Currency is CNY 4.810
-0.050 (-1.03%)
Feb 13, 2026, 3:04 PM CST
SHE:000516 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 4,130 | 4,741 | 4,506 | 2,662 | 2,901 | 1,596 |
Other Revenue | 74.31 | 74.31 | 111.85 | 48.47 | 20.62 | 10.92 |
| 4,205 | 4,815 | 4,618 | 2,711 | 2,921 | 1,607 | |
Revenue Growth (YoY) | -13.85% | 4.28% | 70.34% | -7.20% | 81.78% | 62.17% |
Cost of Revenue | 3,912 | 4,389 | 4,200 | 2,913 | 2,891 | 1,764 |
Gross Profit | 292.31 | 426.31 | 418.28 | -201.57 | 30.23 | -157.01 |
Selling, General & Admin | 529.49 | 548.11 | 646.85 | 632.67 | 656.76 | 450.62 |
Research & Development | 7.32 | 6.99 | 9.81 | 15.51 | 12.8 | 9.69 |
Other Operating Expenses | 62.33 | 61.54 | 68.82 | 38.61 | 28.6 | 15.79 |
Operating Expenses | 595.35 | 622.39 | 741.03 | 693.73 | 704.09 | 483.96 |
Operating Income | -303.04 | -196.08 | -322.75 | -895.3 | -673.87 | -640.97 |
Interest Expense | -150.48 | -173.35 | -219.03 | -190.53 | -190.77 | -154.03 |
Interest & Investment Income | 27.1 | 7.96 | 81.27 | 28.94 | 59.87 | 744.84 |
Currency Exchange Gain (Loss) | - | - | 1.12 | -3.7 | 0.43 | -0.42 |
Other Non Operating Income (Expenses) | -24.36 | -10.26 | -13.03 | -7.51 | -5.59 | -6.06 |
EBT Excluding Unusual Items | -450.77 | -371.74 | -472.42 | -1,068 | -809.93 | -56.64 |
Gain (Loss) on Sale of Investments | 26.09 | 23.77 | 2.1 | -80.79 | -104.36 | 24.11 |
Gain (Loss) on Sale of Assets | 1.19 | 1.66 | 1.95 | 7.25 | -0.17 | -0.3 |
Asset Writedown | -2.59 | -2.59 | -0.87 | -3.36 | -1.9 | -0 |
Other Unusual Items | 4.72 | 4.26 | 1.99 | 4.69 | -3.21 | 40.18 |
Pretax Income | -421.37 | -344.64 | -467.25 | -1,140 | -919.57 | 7.35 |
Income Tax Expense | 23.53 | 20.5 | 4.69 | 55.03 | -74.43 | -27.48 |
Earnings From Continuing Operations | -444.9 | -365.14 | -471.95 | -1,195 | -845.14 | 34.84 |
Minority Interest in Earnings | 109.22 | 111.01 | 103.59 | 18.66 | 22.97 | 10.52 |
Net Income | -335.68 | -254.13 | -368.36 | -1,177 | -822.17 | 45.36 |
Net Income to Common | -335.68 | -254.13 | -368.36 | -1,177 | -822.17 | 45.36 |
Shares Outstanding (Basic) | 2,279 | 2,255 | 2,302 | 2,263 | 2,222 | 2,268 |
Shares Outstanding (Diluted) | 2,279 | 2,255 | 2,302 | 2,263 | 2,222 | 2,268 |
Shares Change (YoY) | 0.24% | -2.06% | 1.74% | 1.84% | -2.03% | 17.91% |
EPS (Basic) | -0.15 | -0.11 | -0.16 | -0.52 | -0.37 | 0.02 |
EPS (Diluted) | -0.15 | -0.11 | -0.16 | -0.52 | -0.37 | 0.02 |
Free Cash Flow | 982.03 | 461.38 | 324.66 | -726.51 | -1,203 | -1,297 |
Free Cash Flow Per Share | 0.43 | 0.20 | 0.14 | -0.32 | -0.54 | -0.57 |
Gross Margin | 6.95% | 8.85% | 9.06% | -7.43% | 1.03% | -9.77% |
Operating Margin | -7.21% | -4.07% | -6.99% | -33.02% | -23.07% | -39.89% |
Profit Margin | -7.98% | -5.28% | -7.98% | -43.41% | -28.15% | 2.82% |
Free Cash Flow Margin | 23.36% | 9.58% | 7.03% | -26.80% | -41.20% | -80.69% |
EBITDA | 356.55 | 510.78 | 447.14 | -274.98 | -105.23 | -264.96 |
EBITDA Margin | 8.48% | 10.61% | 9.68% | -10.14% | -3.60% | -16.49% |
D&A For EBITDA | 659.58 | 706.86 | 769.89 | 620.31 | 568.64 | 376.01 |
EBIT | -303.04 | -196.08 | -322.75 | -895.3 | -673.87 | -640.97 |
EBIT Margin | -7.21% | -4.07% | -6.99% | -33.02% | -23.07% | -39.89% |
Revenue as Reported | 4,205 | 4,815 | 4,618 | 2,711 | 2,921 | 1,607 |
Advertising Expenses | - | 27.2 | 29.65 | 16.62 | 34.92 | 9.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.